Professor Ngs research contributions to AOD-9604 development include: Synthesis and characterization of the modified C-terminal growth hormone fragment with enhanced stability Design of the tyrosine N-terminal modification to improve peptide stability and half-life Preclinical studies demonstrating lipolytic effects in obese animal models Advancement of the peptide through multiple phases of clinical development Investigation of mechanisms underlying beta-3-adrenergic receptor modulation His work established the foundation for understanding peptide-based approaches to metabolic regulation, though clinical translation ultimately proved unsuccessful
That process helps keep the conversation focused on candidacy, safety, and realistic expectations
Premium Quality Formula 120 capsules (60 servings), enhanced with black pepper extract for absorption
The effects of Astragalus, Epimedium, and Fructus Ligustri Lucidi (AEF) extract on the immune function, antioxidant capacity, meat quality, intestinal morphology, and intestinal barrier integrity of goslings were investigated
There is one small pilot study in humans (examining knee pain, where 7 of 12 participants reported sustained improvement beyond 6 months) and a 2025 safety study confirming BPC-157 was well tolerated in healthy adults
